ANI Pharmaceuticals, Inc. (ANIP)

NASDAQ: ANIP · Real-Time Price · USD

80.32

+0.98 (1.24%)

At close: May 19, 2026, 4:00 PM EDT

77.94

-2.38 (-2.96%)

After-hours: May 19, 2026, 5:21 PM EDT

ANI Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	923.71	883.37	614.38	486.82	316.39	216.14
Revenue Growth (YoY)	37.04%	43.78%	26.20%	53.87%	46.38%	3.67%
Cost of Revenue	361.86	341.31	250.21	181.51	138.79	100.61
Gross Profit	561.85	542.06	364.17	305.3	177.6	115.53
Selling, General & Admin	314.87	317.75	249.64	161.7	124.04	84.29
Depreciation & Amortization Expenses	89.45	91.42	67.73	59.79	56.97	47.25
Research & Development	51.7	51.66	44.58	34.29	22.32	11.37
Other Operating Expenses	-17.95	-29.86	12.33	2.56	9.55	12.4
Total Operating Expenses	438.06	430.96	374.28	258.33	212.88	155.32
Operating Income	123.79	111.09	0.58	46.97	-35.28	-39.79
Interest Expense	-18.35	-20.06	-17.6	-26.94	-28.05	-11.92
Other Non-Operating Income (Expense)	10.25	4.76	-16.85	-0.16	0.67	-4.34
Total Non-Operating Income (Expense)	-8.09	-15.3	-34.45	-27.1	-27.38	-16.27
Pretax Income	116.03	95.79	-22.21	19.87	-62.67	-56.06
Provision for Income Taxes	23.88	17.45	-3.69	1.09	-14.77	-13.46
Net Income	56.98	77.18	-18.52	18.78	-47.9	-42.6
Net Income Attributable to Preferred Dividends	-	1.16	-	-	-	-
Net Income to Common	56.98	77.18	-18.52	18.78	-47.9	-42.6
Net Income Growth	1140.63%	-	-	-	-	-
Shares Outstanding (Basic)	20	20	19	18	16	13
Shares Outstanding (Diluted)	21	21	19	18	16	13
Shares Change (YoY)	7.01%	9.89%	6.18%	11.89%	29.77%	4.73%
EPS (Basic)	4.11	3.50	-1.04	0.86	-3.05	-3.40
EPS (Diluted)	3.95	3.32	-1.04	0.85	-3.05	-3.40
Shares Outstanding	22.88	22.49	21.11	20.47	17.49	16.83
Free Cash Flow	-	0	47.78	110.09	-40.08	0.77
Free Cash Flow Growth	-	-	-56.60%	-	-	-91.62%
Free Cash Flow Per Share	-	-	2.47	6.05	-2.46	0.06
Gross Margin	60.83%	61.36%	59.27%	62.71%	56.13%	53.45%
Operating Margin	13.40%	12.58%	0.10%	9.65%	-11.15%	-18.41%
Profit Margin	9.98%	8.87%	-3.01%	3.86%	-15.14%	-19.71%
FCF Margin	-	0.00%	7.78%	22.61%	-12.67%	0.35%
EBITDA	123.79	111.09	68.32	106.76	24.37	7.46
EBITDA Margin	13.40%	12.58%	11.12%	21.93%	7.70%	3.45%
EBIT	123.79	111.09	0.58	46.97	-35.28	-39.79
EBIT Margin	13.40%	12.58%	0.10%	9.65%	-11.15%	-18.41%
Effective Tax Rate	20.58%	18.22%	16.61%	5.50%	23.57%	24.00%

Updated May 8, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q